FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311974484> ?p ?o ?g. }

• W4311974484 endingPage "7316" @default.
• W4311974484 startingPage "7316" @default.
• W4311974484 abstract "The optimal dose of rituximab in combination with leflunomide in patients with rheumatoid arthritis (RA) is not known.In Part 1 (previously reported) of the investigator-initiated AMARA study (EudraCT 2009-015950-39; ClinicalTrials.gov NCT01244958), improvements at week (W)24 were observed in patients randomized to rituximab + leflunomide compared with placebo + leflunomide. In the study reported here (Part 2), Part 1 responders received rituximab 500 or 1000 mg at W24/26 plus ongoing leflunomide. Patients were randomized at baseline to their eventual W24 treatment group. The Part 2 primary outcome was the mean Disease Activity Score-28 joints (DAS28) at W52, based on the last observation carried forward (LOCF) analyses and a two-sided analysis of variance. Patient-reported outcomes (PROs) and adverse events were evaluated.Eighty-three patients received rituximab at W24/26 (31 rituximab→rituximab 1000 mg; 29 rituximab→rituximab 500 mg; 10 placebo→rituximab 1000 mg; 13 placebo→rituximab 500 mg). At W52, there were no significant differences in DAS28 between rituximab doses in patients originally treated with rituximab or those originally treated with placebo. In the Part 1 placebo group, the higher rituximab dose was associated with greater improvements in ACR response rates and some PROs. Adverse events were similar regardless of rituximab dose.Retreatment with rituximab 500 mg and 1000 mg showed comparable efficacy, whereas an initial dose of rituximab 500 mg was associated with lower response rates versus 1000 mg. Reduced treatment response with the lower dose in patients initially treated with placebo may have been influenced by small numbers and baseline disease activity." @default.
• W4311974484 created "2023-01-03" @default.
• W4311974484 creator A5007351753 @default.
• W4311974484 creator A5011323027 @default.
• W4311974484 creator A5012842018 @default.
• W4311974484 creator A5019904842 @default.
• W4311974484 creator A5029412055 @default.
• W4311974484 creator A5032343417 @default.
• W4311974484 creator A5033938525 @default.
• W4311974484 creator A5036865032 @default.
• W4311974484 creator A5040852924 @default.
• W4311974484 creator A5043776691 @default.
• W4311974484 creator A5052265399 @default.
• W4311974484 creator A5060471170 @default.
• W4311974484 creator A5060526475 @default.
• W4311974484 creator A5074627741 @default.
• W4311974484 creator A5088115834 @default.
• W4311974484 creator A5091190600 @default.
• W4311974484 date "2022-12-09" @default.
• W4311974484 modified "2023-10-17" @default.
• W4311974484 title "Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA)" @default.
• W4311974484 cites W2024644107 @default.
• W4311974484 cites W2077158310 @default.
• W4311974484 cites W2113482445 @default.
• W4311974484 cites W2118994799 @default.
• W4311974484 cites W2135856630 @default.
• W4311974484 cites W2143214745 @default.
• W4311974484 cites W2165459235 @default.
• W4311974484 cites W2278084370 @default.
• W4311974484 cites W2411832526 @default.
• W4311974484 cites W2761528156 @default.
• W4311974484 cites W2792050029 @default.
• W4311974484 cites W2897653383 @default.
• W4311974484 cites W2981984395 @default.
• W4311974484 cites W3133467891 @default.
• W4311974484 cites W3134883435 @default.
• W4311974484 cites W4281557842 @default.
• W4311974484 cites W626011147 @default.
• W4311974484 doi "https://doi.org/10.3390/jcm11247316" @default.
• W4311974484 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36555933" @default.
• W4311974484 hasPublicationYear "2022" @default.
• W4311974484 type Work @default.
• W4311974484 citedByCount "0" @default.
• W4311974484 crossrefType "journal-article" @default.
• W4311974484 hasAuthorship W4311974484A5007351753 @default.
• W4311974484 hasAuthorship W4311974484A5011323027 @default.
• W4311974484 hasAuthorship W4311974484A5012842018 @default.
• W4311974484 hasAuthorship W4311974484A5019904842 @default.
• W4311974484 hasAuthorship W4311974484A5029412055 @default.
• W4311974484 hasAuthorship W4311974484A5032343417 @default.
• W4311974484 hasAuthorship W4311974484A5033938525 @default.
• W4311974484 hasAuthorship W4311974484A5036865032 @default.
• W4311974484 hasAuthorship W4311974484A5040852924 @default.
• W4311974484 hasAuthorship W4311974484A5043776691 @default.
• W4311974484 hasAuthorship W4311974484A5052265399 @default.
• W4311974484 hasAuthorship W4311974484A5060471170 @default.
• W4311974484 hasAuthorship W4311974484A5060526475 @default.
• W4311974484 hasAuthorship W4311974484A5074627741 @default.
• W4311974484 hasAuthorship W4311974484A5088115834 @default.
• W4311974484 hasAuthorship W4311974484A5091190600 @default.
• W4311974484 hasBestOaLocation W43119744841 @default.
• W4311974484 hasConcept C126322002 @default.
• W4311974484 hasConcept C142724271 @default.
• W4311974484 hasConcept C168563851 @default.
• W4311974484 hasConcept C197934379 @default.
• W4311974484 hasConcept C204787440 @default.
• W4311974484 hasConcept C27081682 @default.
• W4311974484 hasConcept C2775905006 @default.
• W4311974484 hasConcept C2777575956 @default.
• W4311974484 hasConcept C2779338263 @default.
• W4311974484 hasConcept C2780653079 @default.
• W4311974484 hasConcept C71924100 @default.
• W4311974484 hasConceptScore W4311974484C126322002 @default.
• W4311974484 hasConceptScore W4311974484C142724271 @default.
• W4311974484 hasConceptScore W4311974484C168563851 @default.
• W4311974484 hasConceptScore W4311974484C197934379 @default.
• W4311974484 hasConceptScore W4311974484C204787440 @default.
• W4311974484 hasConceptScore W4311974484C27081682 @default.
• W4311974484 hasConceptScore W4311974484C2775905006 @default.
• W4311974484 hasConceptScore W4311974484C2777575956 @default.
• W4311974484 hasConceptScore W4311974484C2779338263 @default.
• W4311974484 hasConceptScore W4311974484C2780653079 @default.
• W4311974484 hasConceptScore W4311974484C71924100 @default.
• W4311974484 hasIssue "24" @default.
• W4311974484 hasLocation W43119744841 @default.
• W4311974484 hasLocation W43119744842 @default.
• W4311974484 hasLocation W43119744843 @default.
• W4311974484 hasOpenAccess W4311974484 @default.
• W4311974484 hasPrimaryLocation W43119744841 @default.
• W4311974484 hasRelatedWork W1564691722 @default.
• W4311974484 hasRelatedWork W1922756558 @default.
• W4311974484 hasRelatedWork W2074409941 @default.
• W4311974484 hasRelatedWork W2104455431 @default.
• W4311974484 hasRelatedWork W2118084423 @default.
• W4311974484 hasRelatedWork W2332144871 @default.
• W4311974484 hasRelatedWork W2372955595 @default.
• W4311974484 hasRelatedWork W2394123269 @default.
• W4311974484 hasRelatedWork W2783466784 @default.

• next